Pharmaceutical News

RSS

Mark Cuban's cost-plus drug pricing model offers significant savings to patients

A new drug company founded by entrepreneur Mark Cuban could save patients $1.29 billion a year based on 2020 Medicare Part D expenditures on just the nine most popular urological drugs, according to a study published in the Journal of Urology.

10 Feb 2023

Era of ‘free’ covid vaccines, test kits, and treatments is ending. Who will pay the tab now?

Time is running out for free-to-consumer covid vaccines, at-home test kits, and even some treatments.

10 Feb 2023

Single dose of the antibiotic azithromycin decreases sepsis and death risk during childbirth

A single dose of the antibiotic azithromycin can help protect mothers from dangerous sepsis infections and death during vaginal childbirth, a sweeping new international study from a UVA Health scientist and his collaborators has found.

9 Feb 2023

Pegylated interferon lambda shows good efficacy against COVID-19

In a recent study published in The New England Journal of Medicine, researchers used the TOGETHER platform trial protocol to perform a phase III randomized controlled trial (RCT) to evaluate the effectiveness of pegylated interferon (IFN) lambda (λ) therapy in outpatients with coronavirus disease 2019 (COVID-19) in Canada and Brazil.

9 Feb 2023

Novel COVID-19 protein component vaccine elicits durable immune response in rodents

Researchers describe a novel SARS-CoV-2 spike protein component vaccine called MT-001.

9 Feb 2023

Heterologous inactivated virus/mRNA booster strongly augments response to BF.7, BQ.1.1, and XBB.1

Heterologous vaccination improves the neutralization of SARS-CoV-2 Omicron sub-variants.

9 Feb 2023

FDA approves first drug for ESR1-mutated breast cancer

Dr. Rajkumar Lakshmanaswamy, Ph.D., Chair of the Department of Molecular and Translational Medicine, Center of Emphasis in Cancer and Dean of the L. Frederick Francis Graduate School of Biomedical Sciences at Texas Tech University Health Sciences Center El Paso is available to speak on the Federal Drug Administration's approval of the selective estrogen receptor (ER) degrader elacestrant (Orserdu).

9 Feb 2023

Preventing, diagnosing, and treating cardiovascular disease in women

An article published in the journal Medical Clinics of North America provides recent updates on cardiovascular disease prevention, diagnosis, and treatment in women.

8 Feb 2023

In the wake of Chantix's recall, Varenicline use for nicotine dependence dropped by 75%

The recent JAMA Network Open study evaluated how the Chantix recall influenced prescribing varenicline and other nicotine dependency medications. For this cross-sectional study, a large US-based national cohort was used. All relevant data between January 1, 2021, and June 30, 2022, was obtained from the national pharmacy benefit database.

7 Feb 2023

The Pill Club reaches $18.3 million Medicaid fraud settlement with California

The Pill Club, an online women's pharmacy, has reached an $18.3 million settlement with California authorities over claims it defrauded the state's Medicaid program by prescribing birth control pills without adequate consultation and shipping tens of thousands of female condoms to customers who didn't want them.

7 Feb 2023

Bivalent boosters provide additional protection from BA.5, XBB, and XBB.1.5

In a recent Morbidity and Mortality Weekly Report (MMWR) published on the United States Center for Disease Control and Prevention (US-CDC) website, researchers analyzed data from the Increasing Community Access to Testing (ICATT), a nationwide pharmacy program run in the US for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing.

7 Feb 2023

Mucoactive drugs block SARS-CoV-2 infection

Researchers evaluate the effects of mucociliary active molecules on SARS-CoV-2 infection in vitro.

7 Feb 2023

VUMC’s Shed-MEDS protocol reduces exposure to potentially inappropriate medications

An estimated one in six older adults in the United States who take multiple prescription drugs risk major drug-drug interactions and other adverse drug effects that can worsen their medical conditions, increase the likelihood of cognitive impairment and falls, and lead to hospitalization or death.

6 Feb 2023

Gut hormone receptor polyagonists show promise for obesity and diabetes

Previous
1
...
78
79
80
81
82
83
84
...
1453
Next

Pharmaceutical News

Mark Cuban's cost-plus drug pricing model offers significant savings to patients

Era of ‘free’ covid vaccines, test kits, and treatments is ending. Who will pay the tab now?

Single dose of the antibiotic azithromycin decreases sepsis and death risk during childbirth

Pegylated interferon lambda shows good efficacy against COVID-19

Novel COVID-19 protein component vaccine elicits durable immune response in rodents

Heterologous inactivated virus/mRNA booster strongly augments response to BF.7, BQ.1.1, and XBB.1

FDA approves first drug for ESR1-mutated breast cancer

Preventing, diagnosing, and treating cardiovascular disease in women

In the wake of Chantix's recall, Varenicline use for nicotine dependence dropped by 75%

The Pill Club reaches $18.3 million Medicaid fraud settlement with California

Bivalent boosters provide additional protection from BA.5, XBB, and XBB.1.5

Mucoactive drugs block SARS-CoV-2 infection

VUMC’s Shed-MEDS protocol reduces exposure to potentially inappropriate medications

Gut hormone receptor polyagonists show promise for obesity and diabetes

The effectiveness of intranasal COVID-19 vaccination in healthy adults

Blood pressure drug losartan can prevent immunotherapy-induced edema in glioblastoma patients

Pfizer COVID-19 vaccine protects against reinfection in long-term care facility staff

Some antidepressants may be effective in treating chronic pain, but others lack effectiveness

A more nuanced approach is needed when prescribing antidepressants for pain, researchers say

Repeated COVID-19 vaccination may improve public health outcomes

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News